AEterna has a variety of new products in its pipeline. Macrilen, for example, is the first and only FDA-approved oral test for the diagnosis of Adult Growth Hormone Deficiency. AEterna received European approval to market Macrillen. Dr. Christian Strasburger: "Clinical studies have demonstrated that macimorelin is safer and much simpler to administer than the...
I'm a novice but looking at the 1 Month chart looks like a distinct Cup and Handle forming, thoughts???
Based off trend lines. AEZS recently gained compliance Volume has been low the last few days compared to average Earnings to be announced on March 30th
Bullish Indicators - Falling Wedge - Wide RSI Divergence - Aeterna Zentaris to Present at the H.C. Wainwright Global Life Sciences Conference March 9-10
Monday watch list and my trade on OCGN
As you can see we have a textbook Bullish flag pattern. With positive earnings coupled with great news. finance.yahoo.com seekingalpha.com The only downside is that EPS is at -0.18.
We have been monitoring $AEZS for sometime. The stock has crossed key technical indicators. We are bullish. We are are confident the stock will remain relatively stable now that the base of support is forming above the 200EMA. We will also look to buy the stock on weakness. Given that this is a BIOTECH that is dependant on clinical trials and FDA approval,...